Pharma PR & Communications Virtual Summit has ended
avatar for Ken Dominski

Ken Dominski

Bristol Myers Squibb
Executive Director, Lead, Worldwide Oncology Communications
Ken Dominski is Executive Director, Worldwide Oncology Communications at Bristol Myers Squibb where he leads integrated communications and stakeholder engagement for the company’s Oncology portfolio. He began his career at Bristol Myers Squibb in 2006 with responsibility for global and U.S. communications across multiple therapeutic franchises. In 2013 Ken joined corporate affairs and built a team that shaped the company’s reputation and demonstrated progress against business strategy which included accountability for communications across financial/M&A, media, issues and philanthropy. Previous to leading Oncology, he served as head of communications for a team embedded in markets across EMAC and Intercon regions. Ken has also held roles at multiple agencies, including three years at Edelman, in consumer and biopharmaceutical sectors. He holds a Master’s Degree from the Newhouse School at Syracuse University and received his undergraduate degree from Rutgers.

My Speakers Sessions

Thursday, April 22

12:05pm EDT